| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... Medrxiv, 2021.01. 07.21249390, 2021 | 1310 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1015 | 2021 |
| Efficacy of exercise-based cardiac rehabilitation post–myocardial infarction: A systematic review and meta-analysis of randomized controlled trials PR Lawler, KB Filion, MJ Eisenberg American heart journal 162 (4), 571-584. e2, 2011 | 915 | 2011 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 816 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 599 | 2021 |
| Molecular basis for the regulation of angiogenesis by thrombospondin-1 and-2 PR Lawler, J Lawler Cold Spring Harbor perspectives in medicine 2 (5), a006627, 2012 | 553 | 2012 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Epidemiology of shock in contemporary cardiac intensive care units: data from the critical care cardiology trials network registry DD Berg, EA Bohula, S Van Diepen, JN Katz, CL Alviar, VM Baird-Zars, ... Circulation: Cardiovascular Quality and Outcomes 12 (3), e005618, 2019 | 298 | 2019 |
| Targeting cardiovascular inflammation: next steps in clinical translation PR Lawler, DL Bhatt, LC Godoy, TF Lüscher, RO Bonow, S Verma, ... European heart journal 42 (1), 113-131, 2021 | 237 | 2021 |
| Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarction MJ Eisenberg, J Afilalo, PR Lawler, M Abrahamowicz, H Richard, L Pilote Cmaj 183 (4), 430-436, 2011 | 214 | 2011 |
| 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology focused update of the guidelines for the use of antiplatelet therapy SR Mehta, KR Bainey, WJ Cantor, M Lordkipanidzé, G Marquis-Gravel, ... Canadian Journal of Cardiology 34 (3), 214-233, 2018 | 199 | 2018 |
| Circulating branched-chain amino acids and incident cardiovascular disease in a prospective cohort of US women DK Tobias, PR Lawler, PH Harada, OV Demler, PM Ridker, JAE Manson, ... Circulation: Genomic and Precision Medicine 11 (4), e002157, 2018 | 190 | 2018 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 188 | 2021 |
| Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis PR Lawler, KB Filion, T Dourian, R Atallah, M Garfinkle, MJ Eisenberg American heart journal 165 (2), 143-153. e5, 2013 | 184 | 2013 |
| Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-β-dependent and-independent mechanisms WM Miao, W Lin Seng, M Duquette, P Lawler, C Laus, J Lawler Cancer research 61 (21), 7830-7839, 2001 | 178 | 2001 |
| Redefining critical illness DM Maslove, B Tang, M Shankar-Hari, PR Lawler, DC Angus, JK Baillie, ... Nature medicine 28 (6), 1141-1148, 2022 | 159 | 2022 |
| Relations of change in plasma levels of LDL‐C, non‐HDL‐C and apoB with risk reduction from statin therapy: a meta‐analysis of randomized trials G Thanassoulis, K Williams, K Ye, R Brook, P Couture, PR Lawler, ... Journal of the American Heart Association 3 (2), e000759, 2014 | 154 | 2014 |
| Demographics, care patterns, and outcomes of patients admitted to cardiac intensive care units: the Critical Care Cardiology Trials Network Prospective North American … EA Bohula, JN Katz, S Van Diepen, CL Alviar, VM Baird-Zars, JG Park, ... JAMA cardiology 4 (9), 928-935, 2019 | 145 | 2019 |
| Atherogenic lipoprotein determinants of cardiovascular disease and residual risk among individuals with low low‐density lipoprotein cholesterol PR Lawler, AO Akinkuolie, AY Chu, SH Shah, WE Kraus, D Craig, ... Journal of the American Heart Association 6 (7), e005549, 2017 | 136 | 2017 |
| Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence: Prospective data from the Women’s Health Study AW Aday, PR Lawler, NR Cook, PM Ridker, S Mora, AD Pradhan Circulation 138 (21), 2330-2341, 2018 | 111 | 2018 |
Paul M Ridker, MD, MPHEugene Braunwald Professor of Medicine, Harvard Medical SchoolVerified email at partners.org
